Boryung Pharm Cash Flow Conversion Efficiency

Latest as of September 2025: 0.060x

Boryung Pharm cash flow conversion efficiency. Based on the latest financial reports, Boryung Pharm (003850) has a cash flow conversion efficiency ratio of 0.060x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩48.95 Billion ≈ $33.18 Million USD) by net assets (₩818.35 Billion ≈ $554.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Boryung Pharm (2009–2024)

Cash flow conversion efficiency of Boryung Pharm from 2009 to 2024. This chart illustrates how Boryung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Boryung Pharm for real-time trading data and today's change.

Boryung Pharm Cash Flow Conversion Ratio Explained

Boryung Pharm cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Boryung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boryung Pharm ranked by their cash flow conversion efficiency. Also see 003850 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hume Industries Berhad KLSE:5000	0.089x
Studio Dragon Corporation KQ:253450	0.024x
One Liberty Properties Inc NYSE:OLP	0.015x
SWS Hemodialysis Care Co. Ltd. A SHG:688410	N/A
Zhejiang Jindao Technology Co. Ltd. SHE:301279	N/A
Gravity Co Ltd NASDAQ:GRVY	N/A
Shanxi Antai Group Co Ltd SHG:600408	0.063x
Cantor Equity Partners IV, Inc. Class A Ordinary Shares NASDAQ:CEPF	0.000x

Annual Cash Flow Conversion Efficiency for Boryung Pharm (2009–2024)

The table below shows the annual cash flow conversion efficiency of Boryung Pharm from 2009 to 2024. Review 003850 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩784.50 Billion ≈ $531.65 Million	₩80.56 Billion ≈ $54.59 Million	0.103x	+33.57%
2023-12-31	₩549.25 Billion ≈ $372.22 Million	₩42.22 Billion ≈ $28.61 Million	0.077x	+42.73%
2022-12-31	₩516.42 Billion ≈ $349.97 Million	₩27.81 Billion ≈ $18.85 Million	0.054x	-57.54%
2021-12-31	₩474.31 Billion ≈ $321.44 Million	₩60.17 Billion ≈ $40.77 Million	0.127x	-3.52%
2020-12-31	₩340.29 Billion ≈ $230.61 Million	₩44.74 Billion ≈ $30.32 Million	0.131x	-20.84%
2019-12-31	₩282.95 Billion ≈ $191.75 Million	₩47.00 Billion ≈ $31.85 Million	0.166x	+9.32%
2018-12-31	₩256.10 Billion ≈ $173.56 Million	₩38.91 Billion ≈ $26.37 Million	0.152x	+254.12%
2017-12-31	₩249.65 Billion ≈ $169.19 Million	₩-24.61 Billion ≈ $-16.68 Million	-0.099x	-305.69%
2016-12-31	₩195.35 Billion ≈ $132.39 Million	₩9.36 Billion ≈ $6.35 Million	0.048x	-61.98%
2012-12-31	₩145.79 Billion ≈ $98.80 Million	₩18.38 Billion ≈ $12.46 Million	0.126x	+89.34%
2011-12-31	₩137.97 Billion ≈ $93.50 Million	₩9.19 Billion ≈ $6.23 Million	0.067x	-62.35%
2010-12-31	₩136.41 Billion ≈ $92.44 Million	₩24.12 Billion ≈ $16.35 Million	0.177x	+510.22%
2009-12-31	₩124.01 Billion ≈ $84.04 Million	₩3.59 Billion ≈ $2.44 Million	0.029x	--

About Boryung Pharm

KO:003850 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$474.61 Million

₩700.34 Billion KRW

Market Cap Rank

#12145 Global

#330 in Korea

Share Price

₩8290.00

Change (1 day)

+0.00%

52-Week Range

₩7570.00 - ₩10680.00

All Time High

₩21257.60